Advances in Immunotherapy in Esophagogastric Cancer
Hematology/Oncology Clinics of North America(2024)
摘要
Immune checkpoint inhibitors are rapidly transforming the care of patients with esophagogastric cancer. Particularly, anti-PD-1 therapy has demonstrated promising efficacy in metastatic and resectable disease. In this review, the authors discuss landmark clinical trials, highlight challenges and opportunities in this field, and propose potential directions for future work.
更多查看译文
关键词
Immunotherapy,Immune checkpoint inhibitor,PD-1,PD-L1,Esophageal,Gastroesophageal,Cancer,Malignancy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要